Sean Brynjelsen
Director Ejecutivo en ETON PHARMACEUTICALS, INC. .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Sean Brynjelsen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ETON PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2017 | - |
| Director Ejecutivo | 01/06/2017 | - | |
| Presidente | 01/06/2017 | - |
Historial de carrera de Sean Brynjelsen
Antiguos cargos conocidos de Sean Brynjelsen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | 23/03/2016 | 01/06/2017 |
| AKORN, INC. | Director Técnico/Científico/I+D | 18/06/2010 | 07/02/2014 |
| Corporate Officer/Principal | 07/02/2014 | 01/03/2016 |
Formación de Sean Brynjelsen.
| University of Notre Dame | Masters Business Admin |
| University of Illinois | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Sean Brynjelsen
- Experiencia
